Azacytidine Plus Chidamide in the Treatment of Relapsed and Refractory Angioimmunoblastic T-cell Lymphoma
Conditions
- Angioimmunoblastic T-cell Lymphoma
Interventions
- DRUG: Azacitidine
- DRUG: Chidamide
Sponsor
Peking Union Medical College Hospital
Collaborators